Bolt Biotherapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Bolt Biotherapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $400K, unchanged year-over-year.
  • Bolt Biotherapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.9M, a 5.56% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2023 was $1.9M, a 11.8% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2022 was $1.7M, a 41.7% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2021 was $1.2M, a 100% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.9M +$200K +11.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.7M +$500K +41.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $1.2M +$600K +100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $600K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.